Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2203 (LINC02203)
- Target
- LINC02203
- Molecular classification
- Long intergenic non-coding RNA (lincRNA), Long non-coding RNA (lncRNA)
01
Overview
LINC02203 (Long intergenic non-protein coding RNA 2203) is a non-coding RNA gene that produces a lincRNA transcript. Like other lincRNAs, it does not overlap protein-coding regions and is not translated into protein. LincRNAs typically function by remodeling chromatin, regulating transcription, and fine-tuning the expression of neighboring genes in a tissue-specific manner. LINC02203 is highly expressed in osteoarthritis cartilage, suggesting potential involvement in cartilage biology, cell proliferation, and ECM maintenance, although its specific molecular functions remain to be clarified and few studies have targeted this gene directly. No drug-interactions, biomarker roles, or therapeutic classifications exist for this molecule at this time.
- Other names
- LINC02203LOC727924
02
Biological functions
Likely involved in regulation of gene expression and chromatin structure, typical for lincRNAsMay play a role in cell proliferation and extracellular matrix (ECM) dynamics, based on RNA-seq evidence in osteoarthritis cartilage
03
Disease associations
Osteoarthritis (high expression in OA cartilage, potential involvement in ECM degradation and cell proliferation)Other: no major roles for cancer, inflammation, or other diseases currently documented for LINC02203
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2203 (LINC02203).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2203 (LINC02203).